New MRI technique aims to detect hidden heart harm from cancer radiation

NCT ID NCT04044872

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This early-phase study tested whether a special MRI technique could detect early signs of heart damage caused by radiation therapy in people with thoracic or left-sided breast cancer. The approach used an injected substance (hyperpolarized pyruvate) to measure changes in heart cell energy use. Only 3 participants were enrolled before the study was terminated, so results are very limited.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
hyperpolarized [1-13C]pyruvate
What this could lead to
If successful, this imaging technique could help doctors detect radiation-induced heart damage earlier, potentially guiding safer radiation plans.
What could go wrong
This was a very small, early feasibility study that was terminated before completion. The method is still experimental and may not prove useful in larger, more diverse groups.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for LEFT SIDED BREAST CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

breast cancer breast carcinoma Cardiotoxicity thoracic cancer Unilateral Breast Neoplasms

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Department of Radiation Oncology; UT Southwestern Medical Center

    Dallas, Texas, 75390, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.